Literature DB >> 8670141

Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor.

R Birkenhäger1, B Schneppe, W Röckl, J Wilting, H A Weich, J E McCarthy.   

Abstract

Vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) are members of a dimeric-growth-factor family with angiogenic properties. VEGF is a highly potent and specific mitogen for endothelial cells, playing a vital role in angiogenesis in vivo. The role of PIGF is less clear. We expressed the monomeric splice forms VEGF-165, VEGF-121, PIGF-1 and PIGF-2 as unfused genes in Escherichia coli using the pCYTEXP expression system. In vitro dimerization experiments revealed that both homo- and hetero-dimers can be formed from these monomeric proteins. The dimers were tested for their ability to promote capillary growth in vivo and stimulate DNA synthesis in cultured human vascular endothelial cells. Heterodimers comprising different VEGF splice forms, or combinations of VEGF/PIGF splice forms, showed mitogenic activity. The results demonstrate that four different heterodimeric growth factors are likely to have as yet uncharacterized functions in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670141      PMCID: PMC1217407          DOI: 10.1042/bj3160703

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain.

Authors:  A Hammacher; U Hellman; A Johnsson; A Ostman; K Gunnarsson; B Westermark; A Wasteson; C H Heldin
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

2.  Two classes of PDGF receptor recognize different isoforms of PDGF.

Authors:  C E Hart; J W Forstrom; J D Kelly; R A Seifert; R A Smith; R Ross; M J Murray; D F Bowen-Pope
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

3.  Expression of synthetic genes encoding bovine and human basic fibroblast growth factors (bFGFs) in Escherichia coli.

Authors:  W Knoerzer; H P Binder; K Schneider; P Gruss; J E McCarthy; W Risau
Journal:  Gene       Date:  1989-01-30       Impact factor: 3.688

4.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.

Authors:  B Millauer; L K Shawver; K H Plate; W Risau; A Ullrich
Journal:  Nature       Date:  1994-02-10       Impact factor: 49.962

7.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.

Authors:  J Wilting; B Christ; M Bokeloh; H A Weich
Journal:  Cell Tissue Res       Date:  1993-10       Impact factor: 5.249

8.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

9.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

Authors:  B I Terman; M Dougher-Vermazen; M E Carrion; D Dimitrov; D C Armellino; D Gospodarowicz; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

10.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types.

Authors:  C H Heldin; G Bäckström; A Ostman; A Hammacher; L Rönnstrand; K Rubin; M Nistér; B Westermark
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  7 in total

1.  Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity.

Authors:  I Lang; C Hoffmann; H Olip; M A Pabst; T Hahn; G Dohr; G Desoye
Journal:  Cell Prolif       Date:  2001-06       Impact factor: 6.831

2.  VEGF induces cardiovascular malformation and embryonic lethality.

Authors:  M Feucht; B Christ; J Wilting
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 3.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

4.  VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.

Authors:  Raúl Catena; Leyre Larzabal; Marta Larrayoz; Eva Molina; Jose Hermida; Jackeline Agorreta; Ramon Montes; Ruben Pio; Luis M Montuenga; Alfonso Calvo
Journal:  Mol Cancer       Date:  2010-12-31       Impact factor: 27.401

5.  Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.

Authors:  Ariadne Malamitsi-Puchner; Theodora Boutsikou; Emmanuel Economou; Angeliki Sarandakou; Evangelos Makrakis; Dimitrios Hassiakos; George Creatsas
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

6.  Vascular endothelial growth factor induces endothelial fenestrations in vitro.

Authors:  S Esser; K Wolburg; H Wolburg; G Breier; T Kurzchalia; W Risau
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

7.  Physical activity differentially regulates VEGF, PlGF, and their receptors in the human placenta.

Authors:  Jayonta Bhattacharjee; Shuhiba Mohammad; Alexandra D Goudreau; Kristi B Adamo
Journal:  Physiol Rep       Date:  2021-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.